Publications

  1. Saul JE, Bonito JA, Provan K, Ruppel E, Leischow SJ. Implementation of tobacco cessation quitline practices in the United States and Canada. Am J Public Health. 2014 Oct; 104(10):e98-105. Epub 2014 Aug 14.
    View PubMed
  2. Nides MA, Leischow SJ, Bhatter M, Simmons M. Nicotine Blood Levels and Short-term Smoking Reduction with an Electronic Nicotine Delivery System. Am J Health Behav. 2014 Mar; 38(2):265-74.
    View PubMed
  3. Herbst RS, Hobin JA, Gritz ER, Aberle D, Brandon TH, Fong GT, Grandis JR, Hatsukami DK, Hawk E, Hong WK, Khuri FR, Leischow SJ, Shields PG, Toll BA, Viswanath K, Warren G, Land SR. AACR celebrates 50 years of tobacco research and policy. Clin Cancer Res. 2014; 20(7):1709-18.
  4. Cui K, Zheng X, Zeng D, Leischow S. An empirical analysis on communications about Electronic Nicotine Delivery Systems (ENDS) in Chinese social media. Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics). 2014; 8549 LNCS(4):37-43.
  5. Toll BA, Brandon TH, Gritz ER, Warren GW, Herbst RS, AACR Subcommittee on Tobacco and Cancer. Assessing tobacco use by cancer patients and facilitating cessation: an American Association for Cancer Research policy statement. Clin Cancer Res. 2013 Apr 15; 19(8):1941-8. Epub 2013 Apr 9.
    View PubMed
  6. Leischow SJ, Ayo-Yusuf O, Backinger CL. Converging research needs across framework convention on tobacco control articles: making research relevant to global tobacco control practice and policy. Nicotine Tob Res. 2013 Apr; 15(4):761-6. Epub 2012 Sep 18.
    View PubMed
  7. Giovino GA, Kulak JA, Kalsbeek WD, Leischow SJ. Research priorities for FCTC Articles 20, 21, and 22: surveillance/evaluation and information exchange. Nicotine Tob Res. 2013 Apr; 15(4):847-61. Epub 2013 Jan 18.
    View PubMed
  8. Bonito JA, Ruppel EK, Saul JE, Leischow SJ. Assessing the preconditions for communication influence on decision making: the North American Quitline Consortium. Health Commun. 2013; 28(3):248-59. Epub 2012 May 14.
    View PubMed
  9. Liang Y, Zheng X, Zeng DD, Zhou X, Leischow S. An empirical analysis of social interaction on tobacco-oriented social networks. Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics). 2013; 8040 LNCS:18-23.
  10. Luo C, Zheng X, Zeng DD, Leischow S, Cui K, Zhang Z, He S. Portrayal of electronic cigarettes on YouTube. Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics). 2013; 8040 LNCS:1-6.
  11. Zhang Z, Zheng X, Zeng DD, Cui K, Luo C, He S, Leischow S. Discovering seasonal patterns of smoking behavior using online search information. IEEE ISI 2013 - 2013 IEEE International Conference on Intelligence and Security Informatics: Big Data, Emergent Threats, and Decision-Making in Security Informatics. 2013; 371-3.
  12. Leischow SJ, Provan K, Beagles J, Bonito J, Ruppel E, Moor G, Saul J. Mapping tobacco quitlines in North America: signaling pathways to improve treatment. Am J Public Health. 2012 Nov; 102(11):2123-8. Epub 2012 Sep 20.
    View PubMed
  13. Guy MC, Seltzer RG, Cameron M, Pugmire J, Michael S, Leischow SJ. Relationship between smokers' modes of entry into quitlines and treatment outcomes. Am J Health Behav. 2012 Jan; 36(1):3-11.
    View PubMed
  14. Hatsukami DK, Biener L, Leischow SJ, Zeller MR. Tobacco and nicotine product testing. Nicotine Tob Res. 2012 Jan; 14(1):7-17. Epub 2011 Apr 02.
    View PubMed
  15. Harris JK, Provan KG, Johnson KJ, Leischow SJ. Drawbacks and benefits associated with inter-organizational collaboration along the discovery-development-delivery continuum: a cancer research network case study. Implement Sci. 2012; 7:69. Epub 2012 Jul 25.
    View PubMed
  16. Provan KG, Beagles JE, Leischow SJ. Network formation, governance, and evolution in public health: the North American Quitline Consortium case. Health Care Manage Rev. 2011 Oct-Dec; 36(4):315-26.
    View PubMed
  17. Provan KG, Leischow SJ, Keagy J, Nodora J. Research collaboration in the discovery, development, and delivery networks of a statewide cancer coalition. Eval Program Plann. 2010 Nov; 33(4):349-55. Epub 2009 Dec 16.
    View PubMed
  18. Leischow SJ, Luke DA, Mueller N, Harris JK, Ponder P, Marcus S, Clark PI. Mapping U.S. government tobacco control leadership: networked for success? Nicotine Tob Res. 2010 Sep; 12(9):888-94. Epub 2010 Aug 05.
    View PubMed
  19. Hays JT, Leischow SJ, Lawrence D, Lee TC. Adherence to treatment for tobacco dependence: association with smoking abstinence and predictors of adherence. Nicotine Tob Res. 2010 Jun; 12(6):574-81. Epub 2010 May 10.
    View PubMed
  20. Viswanath K, Herbst RS, Land SR, Leischow SJ, Shields PG, Writing Committee for the AACR Task Force on Tobacco and Cancer. Tobacco and cancer: an American Association for Cancer Research policy statement. Cancer Res. 2010 May 1; 70(9):3419-30. Epub 2010 Apr 13.
    View PubMed
  21. Zeller M, Hatsukami D, Strategic Dialogue on Tobacco Harm Reduction Group. The Strategic Dialogue on Tobacco Harm Reduction: a vision and blueprint for action in the US. Tob Control. 2009 Aug; 18(4):324-32. Epub 2009 Feb 24.
    View PubMed
  22. Cohen JE, Zeller M, Eissenberg T, Parascandola M, O'Keefe R, Planinac L, Leischow S. Criteria for evaluating tobacco control research funding programs and their application to models that include financial support from the tobacco industry. Tob Control. 2009 Jun; 18(3):228-34. Epub 2009 Feb 24.
    View PubMed
  23. Leischow SJ. Setting the national tobacco control agenda. JAMA. 2009 Mar 11; 301(10):1058-60.
    View PubMed
  24. Hawk ET, Greenwood A, Gritz ER, McTiernan A, Sellers T, Hursting SD, Leischow S, Grad O, Translational Research Working Group. The Translational Research Working Group developmental pathway for lifestyle alterations. Clin Cancer Res. 2008 Sep 15; 14(18):5707-13.
    View PubMed
  25. Leischow SJ, Best A, Trochim WM, Clark PI, Gallagher RS, Marcus SE, Matthews E. Systems thinking to improve the public's health. Am J Prev Med. 2008 Aug; 35(2 Suppl):S196-203.
    View PubMed
  26. Muramoto ML, Leischow SJ, Sherrill D, Matthews E, Strayer LJ. Randomized, double-blind, placebo-controlled trial of 2 dosages of sustained-release bupropion for adolescent smoking cessation. Arch Pediatr Adolesc Med. 2007 Nov; 161(11):1068-74.
    View PubMed
  27. Morgan GD, Backinger CL, Leischow SJ. The future of tobacco-control research. Cancer Epidemiol Biomarkers Prev. 2007 Jun; 16(6):1077-80.
    View PubMed
  28. Nides M, Leischow S, Sarna L, Evans SE. Maximizing smoking cessation in clinical practice: pharmacologic and behavioral interventions. Prev Cardiol. 2007 Spring; 10(2 Suppl 1):23-30.
    View PubMed
  29. Rennard SI, Glover ED, Leischow S, Daughton DM, Glover PN, Muramoto M, Franzon M, Danielsson T, Landfeldt B, Westin A. Efficacy of the nicotine inhaler in smoking reduction: A double-blind, randomized trial. Nicotine Tob Res. 2006 Aug; 8(4):555-64.
    View PubMed
  30. Trochim WM, Cabrera DA, Milstein B, Gallagher RS, Leischow SJ. Practical challenges of systems thinking and modeling in public health. Am J Public Health. 2006 Mar; 96(3):538-46. Epub 2006 Jan 31.
    View PubMed
  31. Hatsukami DK, Giovino GA, Eissenberg T, Clark PI, Lawrence D, Leischow S. Methods to assess potential reduced exposure products. Nicotine Tob Res. 2005 Dec; 7(6):827-44.
    View PubMed
  32. Stillman FA, Wipfli HL, Lando HA, Leischow S, Samet JM. Building capacity for international tobacco control research: the global tobacco research network. Am J Public Health. 2005 Jun; 95(6):965-8.
    View PubMed
  33. Leischow SJ, Ranger-Moore J, Muramoto ML, Matthews E. Effectiveness of the nicotine inhaler for smoking cessation in an OTC setting. Am J Health Behav. 2004 Jul-Aug; 28(4):291-301.
    View PubMed
  34. Clark PI, Gardiner PS, Djordjevic MV, Leischow SJ, Robinson RG. Menthol cigarettes: setting the research agenda. Nicotine Tob Res. 2004 Feb; 6 Suppl 1:S5-9.
    View PubMed
  35. Best A, Moor G, Holmes B, Clark PI, Bruce T, Leischow S, Buchholz K, Krajnak J. Health promotion dissemination and systems thinking: towards an integrative model. Am J Health Behav. 2003 Nov-Dec; 27 Suppl 3:S206-16.
    View PubMed
  36. Best A, Stokols D, Green LW, Leischow S, Holmes B, Buchholz K. An integrative framework for community partnering to translate theory into effective health promotion strategy. Am J Health Promot. 2003 Nov-Dec; 18(2):168-76.
    View PubMed
  37. Muramoto ML, Ranger-Moore J, Leischow SJ. Efficacy of oral transmucosal nicotine lozenge for suppression of withdrawal symptoms in smoking abstinence. Nicotine Tob Res. 2003 Apr; 5(2):223-30.
    View PubMed
  38. Smith SS, Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Jamerson B, Fiore MC, Baker TB. Targeting smokers at increased risk for relapse: treating women and those with a history of depression. Nicotine Tob Res. 2003 Feb; 5(1):99-109.
    View PubMed
  39. Durcan MJ, White J, Jorenby DE, Fiore MC, Rennard SI, Leischow SJ, Nides MA, Ascher JA, Johnston JA. Impact of prior nicotine replacement therapy on smoking cessation efficacy. Am J Health Behav. 2002 May-Jun; 26(3):213-20.
    View PubMed
  40. Hatsukami DK, Slade J, Benowitz NL, Giovino GA, Gritz ER, Leischow S, Warner KE. Reducing tobacco harm: research challenges and issues. Nicotine Tob Res. 2002; 4 Suppl 2:S89-101.
    View PubMed
  41. Shaw JW, Coons SJ, Foster SA, Leischow SJ, Hays RD. Responsiveness of the Smoking Cessation Quality of Life (SCQoL) questionnaire. Clin Ther. 2001 Jun; 23(6):957-69.
    View PubMed
  42. Jamerson BD, Nides M, Jorenby DE, Donahue R, Garrett P, Johnston JA, Fiore MC, Rennard SI, Leischow SJ. Late-term smoking cessation despite initial failure: an evaluation of bupropion sustained release, nicotine patch, combination therapy, and placebo. Clin Ther. 2001 May; 23(5):744-52.
    View PubMed
  43. Backinger CL, Leischow SJ. Advancing the science of adolescent tobacco use cessation. Am J Health Behav. 2001 May-Jun; 25(3):183-90.
    View PubMed
  44. Rohrbaugh MJ, Shoham V, Trost S, Muramoto M, Cate RM, Leischow S. Couple dynamics of change-resistant smoking: toward a family consultation model. Fam Process. 2001 Spring; 40(1):15-31.
    View PubMed
  45. Muramoto ML, Connolly T, Strayer LJ, Ranger-Moore J, Blatt W, Leischow R, Leischow S. Tobacco cessation skills certification in Arizona: application of a state wide, community based model for diffusion of evidence based practice guidelines. Tob Control. 2000 Dec; 9(4):408-14.
    View PubMed
  46. Leischow SJ, Ranger-Moore J, Lawrence D. Addressing social and cultural disparities in tobacco use. Addict Behav. 2000 Nov-Dec; 25(6):821-31.
    View PubMed
  47. Hill AL, Roe DJ, Taren DL, Muramoto MM, Leischow SJ. Efficacy of transdermal nicotine in reducing post-cessation weight gain in a Hispanic sample. Nicotine Tob Res. 2000 Aug; 2(3):247-53.
    View PubMed
  48. Olufade AO, Shaw JW, Foster SA, Leischow SJ, Hays RD, Coons SJ. Development of the Smoking Cessation Quality of Life questionnaire. Clin Ther. 1999 Dec; 21(12):2113-30.
    View PubMed
  49. Hughes JR, Lesmes GR, Hatsukami DK, Richmond RL, Lichtenstein E, Jorenby DE, Broughton JO, Fortmann SP, Leischow SJ, McKenna JP, Rennard SI, Wadland WC, Heatley SA. Are higher doses of nicotine replacement more effective for smoking cessation? Nicotine Tob Res. 1999 Jun; 1(2):169-74.
    View PubMed
  50. Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Hughes AR, Smith SS, Muramoto ML, Daughton DM, Doan K, Fiore MC, Baker TB. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med. 1999 Mar 4; 340(9):685-91.
    View PubMed
  51. Leischow SJ, Merikle EP, Cook G, Newman R, Muramoto M. An evaluation of NicCheck I: a dipstick method for analyzing nicotine and its metabolites. Addict Behav. 1999 Jan-Feb; 24(1):145-8.
    View PubMed
  52. Leischow SJ, Muramoto ML, Cook GN, Merikle EP, Castellini SM, Otte PS. OTC nicotine patch: effectiveness alone and with brief physician intervention. Am J Health Behav. 1999; 23(1):61-9.
  53. Glover ED, Leischow SJ, Rennard SI, Glover PN, Daughton D, Quiring JN, Schneider FH, Mione PJ. A smoking cessation trial with Lobeline Sulfate: a pilot study. Am J Health Behav. 1998; 22(1):62-74.
  54. Schneider NG, Jacob P 3rd, Nilsson F, Leischow SJ, Benowitz NL, Olmstead RE. Saliva cotinine levels as a function of collection method. Addiction. 1997 Mar; 92(3):347-51.
    View PubMed
  55. Leischow SJ, Valente SN, Hill AL, Otte PS, Aickin M, Holden T, Kligman E, Cook G. Effects of nicotine dose and administration method on withdrawal symptoms and side effects during short-term smoking abstinence. Exp Clin Psychopharmacol. 1997 Feb; 5(1):54-64.
    View PubMed
  56. Miller MJ, Draugalis JR, Ortmeier BG, Leischow SJ. A retrospective analysis of the costs and consequences of a tobacco-cessation program for active duty service members. Mil Med. 1996 Jul; 161(7):420-4.
    View PubMed
  57. Ker M, Leischow S, Markowitz IB, Merikle E. Involuntary smoking cessation: a treatment option in chemical dependency programs for women and children. J Psychoactive Drugs. 1996 Jan-Mar; 28(1):47-60.
    View PubMed
  58. Leischow SJ, Hill A, Cook G, Muramoto M, Lundergan L. The effects of transdermal nicotine for the treatment of Hispanic smokers. Am J Health Behav. 1996; 20(5):304-11.
  59. Leischow SJ, Nilsson F, Franzon M, Hill A, Otte PS, Merikle EP. Efficacy of the nicotine inhaler as an adjunct to smoking cessation. Am J Health Behav. 1996; 20(5):364-71.
  60. Leischow SJ, Sachs DP, Hansen MD, Bostrom AG. Nicotine polacrilex dose effects: serum nicotine levels and sensory characteristics. Psychopharmacology (Berl). 1995 Jan; 117(2):125-9.
    View PubMed
  61. Lunell E, Molander L, Leischow SJ, Fagerstrom KO. Effect of nicotine vapour inhalation on the relief of tobacco withdrawal symptoms. Eur J Clin Pharmacol. 1995; 48(3-4):235-40.
    View PubMed
  62. Leischow SJ, Bigelow GE. Stress reactivity: a simple classroom demonstration. J Health Educ. 1994; 25:101-2.
  63. Leischow SJ. The nicotine vaporizer. Health Values. 1994; 18:4-9.
  64. Sachs DP, Sawe U, Leischow SJ. Effectiveness of a 16-hour transdermal nicotine patch in a medical practice setting, without intensive group counseling. Arch Intern Med. 1993 Aug 23; 153(16):1881-90.
    View PubMed
  65. Leischow SJ, Sachs DP, Bostrom AG, Hansen MD. Effects of differing nicotine-replacement doses on weight gain after smoking cessation. Arch Fam Med. 1992 Nov; 1(2):233-7.
    View PubMed
  66. Chornock WM, Stitzer ML, Gross J, Leischow S. Experimental model of smoking re-exposure: effects on relapse. Psychopharmacology (Berl). 1992; 108(4):495-500.
    View PubMed
  67. Henningfield JE, Obarzanek E, Benowitz NL, Hall SM, Klesges RC, Leischow S, Levin ED, Perkins KA, Spring B, Stitzer M, et al. National working conference on smoking and body weight. Task Force 2: Methods of assessment, strategies for research. Health Psychol. 1992; 11 Suppl:10-6.
    View PubMed
  68. Sachs DP, Leischow SJ. Pharmacologic approaches to smoking cessation. Clin Chest Med. 1991 Dec; 12(4):769-91.
    View PubMed
  69. Leischow SJ, Stitzer ML. Smoking cessation and weight gain. Br J Addict. 1991 May; 86(5):577-81.
    View PubMed
  70. Leischow SJ, Stitzer ML. Effects of smoking cessation on caloric intake and weight gain in an inpatient unit. Psychopharmacology (Berl). 1991; 104(4):522-6.
    View PubMed